Cholesterol and Atherosclerosis

Frontiers | Nano-drug delivery systems (NDDS) i...

Schematic description of the main routes of ste...

Identification and evaluation of a lipid-loweri...

Acetyl CoA Carboxylase Inhibition Reduces Hepat...

G protein-coupled receptor 35 attenuates nonalc...

Proposed mechanisms of action of CM414 involved...

Figure 4 from The metabolic adaptation of bile ...

Upregulated CYP 2E1 promotes the development of...

AMPK/mTOR pathway significance in healthy liver...

ATP-citrate lyase (ACLY) is an enzyme possessin...

Antioxidants | Free Full-Text | N-Acetyl Cystei...

Proposed mechanism of action of treatments for ...

(PDF) Thyroid hormone action in metabolic regul...

The mechanisms of major metabolic targets regul...

Lipid metabolism. The mobilization of fatty aci...

The Effect of Coenzyme Q10 Supplementation on B...

IJMS | Free Full-Text | MyD88 in Macrophages En...

(PDF) Cholesterol and Inflammation at the Cross...

Madrigal Pharmaceuticals Setting The Standard (...

Metabolic alterations resulting in hepatic trig...

Full article: Thyroid hormone induction of mito...

Bempedoic Acid, the First-in-Class Oral ATP Cit...

Figure 1 from Gut microbiota and non-alcoholic ...

Benefits of lifestyle modification in NAFLD | Gut

Applications of the Cholesterol Metabolite, 4β-...

Schematic diagram representing the roles of die...

P(URI)fying Novel Drivers of NASH and HCC: A Fe...

Marine Drugs | Free Full-Text | Saringosterol f...

Physiological Suppression of Lipotoxic Liver Da...

Pathophysiology of non-alcoholic fatty liver di...

Antioxidant Activity of γ-Oryzanol: A Complex N...

DHA-Enriched Phosphatidylserine Combats NAFLD &...

Frontiers | miRNA Dysregulation in the Developm...

New cardiovascular prevention guidelines: How t...

Marine Drugs | Free Full-Text | Fucoidan and Fu...